Ross Feller Casey is investigating potential litigation on behalf of boys and young men who have developed painful, enlarged breasts after using the anti-psychotic drug Risperdal.
Studies have shown that boys and young men who have taken Risperdal produce increased levels of prolactin, a hormone that stimulates breast growth and milk production. As a result, many have developed female-like breasts in a medical condition known as gynecomastia, which is irreversible, potentially embarrassing and can cause psychological trauma.
Pharmaceutical giant Johnson & Johnson has already agreed to pay the federal government $2.2 billion to settle civil and criminal allegations involving its marketing of Risperdal and other drugs for unapproved uses.
The number of separate civil cases continues to swell and now stands at more than 200.
To contact one of our Risperdal attorneys.